These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8450612)

  • 1. [Evaluation of the benefits of sodium 2-mercaptoethane sulfonate (MESNA) therapy for children undergoing high-dose chemotherapy].
    Sato J; Takaue Y; Saito S; Okamoto Y; Hirao A; Shimizu T; Abe T; Watanabe T; Kawano Y; Ninomiya T
    Rinsho Ketsueki; 1993 Jan; 34(1):7-12. PubMed ID: 8450612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prevention of hemorrhagic cystitis during the performance of bone marrow and peripheral blood stem cell transplantation in the hematologic cancer clinic].
    Uss AL; Milanovich NF; Snegir' VM; Zmachinskiĭ VA; Skriagin AE
    Ter Arkh; 1996; 68(10):49-52. PubMed ID: 9026944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A; Korkmaz A; Oter S; Coskun O
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
    Grañena A; Gardella S; Marín P; Carreras E; Montserrat E; Rozman C
    Sangre (Barc); 1986; 31(3):307-10. PubMed ID: 3092373
    [No Abstract]   [Full Text] [Related]  

  • 8. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Tsuboi K; Kishi K; Ohmachi K; Yasuda Y; Shimizu T; Inoue H; Matsumoto M; Hattori K; Yoshiba F; Watanabe S; Ogawa Y; Kawada H; Yabe H; Yabe M; Kato S; Hotta T
    Bone Marrow Transplant; 2003 Nov; 32(9):903-7. PubMed ID: 14561991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
    Shepherd JD; Pringle LE; Barnett MJ; Klingemann HG; Reece DE; Phillips GL
    J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults.
    Kohno A; Takeyama K; Narabayashi M; Tamayose K; Watanabe T; Adachi I; Tobisu K; Tobinai K; Shimoyama M
    Jpn J Clin Oncol; 1993 Feb; 23(1):46-52. PubMed ID: 8459641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic cystitis--a manifestation of graft versus host disease?
    Ost L; Lönnqvist B; Eriksson L; Ljungman P; Ringdén O
    Bone Marrow Transplant; 1987 Jun; 2(1):19-25. PubMed ID: 3139114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
    Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER
    J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhagic cystitis after conditioning for bone marrow transplantation and its prophylaxis.
    Moriyama Y; Koike T; Shibata A
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():531-6. PubMed ID: 6441037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation].
    Xu HG; Fang JP; Huang SL; Zhou DH; Chen C; Huang K; Li Y
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):126-30. PubMed ID: 16624030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.
    Ballen KK; Becker P; Levebvre K; Emmons R; Lee K; Levy W; Stewart FM; Quesenberry P; Lowry P
    Oncology; 1999 Nov; 57(4):287-92. PubMed ID: 10575313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemorrhagic cystitis related to the high-dose conditioning therapy in a bone marrow recipient].
    Machaczka M; Rucińska M; Piatkowska-Jakubas B; Załuska A; Skotnicki AB
    Przegl Lek; 2001; 58(1):51-3. PubMed ID: 11450158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support.
    Meisenberg B; Lassiter M; Hussein A; Ross M; Vredenburgh JJ; Peters WP
    Bone Marrow Transplant; 1994 Aug; 14(2):287-91. PubMed ID: 7994244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine.
    Jiang Q; Huang H; Liu Q; Sun J; Zhou H; Fan Z; Zhang Y; Huang F; Chai Y; Xu D; Lu Y; Wei Q; Yu G; Li X; Dai M; Xu N; Zhou D; Zhao H; Shen K; Mai Q; Zhou Y; Meng F
    Bone Marrow Transplant; 2015 Nov; 50(11):1490-2. PubMed ID: 26367223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.